Together, these results demonstrate that excessive BRIX1 counteracts nucleolar stress‐mediated anti‐tumor effects by inactivating p53, suggesting the involvement of BRIX1 in fostering resistance to chemotherapy. Here, TP53 is linked to neoplasm.